Literature DB >> 16372297

Transmission in vitro of hepatitis C virus from persistently infected human B-cells to hepatoma cells by cell-to-cell contact.

Maria Beatrice Valli1, Annalucia Serafino, Annalisa Crema, Luisa Bertolini, Aldo Manzin, Giulia Lanzilli, Cesare Bosman, Silvia Iacovacci, Sergio Giunta, Antonio Ponzetto, Massimo Clementi, Guido Carloni.   

Abstract

Virus cell-to-cell spread has been reported for many different viruses and may contribute to pathogenesis of viral disease. The role played by cell-to-cell contact in hepatitis C virus (HCV) transmission was studied in vitro by cell co-cultivation experiments. A human lymphoblastoid B-cell line, infected persistently with HCV in vitro (TO.FE(HCV)), was used as HCV donor [Serafino et al., 2003]; recipient cells were the human hepatoma HepG2 cell line. Both cell types were co-cultured for 48 hr to allow the cell-to-cell contacts. The hepatoma HepG2 cells are not permissive to free-virus infection, but they were infected successfully using TO.FE(HCV) cells as source of virus. The kinetics of viral RNA synthesis and the percentage of infected cells were compared in cell-mediated-and cell-free-viral infection. After co-cultivation, a consistent proportion of hepatoma cells replicated HCV and stably expressed viral antigens. Virus produced was infectious as demonstrated by the ability to reinfect fresh B-cells. This cell model shows that permissiveness to HCV infection can be achieved in vitro in non-permissive hepatoma cells by direct cell-to-cell contacts with infected human B-cells. This mechanism of virus spread may also play a pathogenic role in vivo. Copyright 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2006        PMID: 16372297     DOI: 10.1002/jmv.20527

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  12 in total

1.  Oligonucleotide-Lipid Conjugates Forming G-Quadruplex Structures Are Potent and Pangenotypic Hepatitis C Virus Entry Inhibitors In Vitro and Ex Vivo.

Authors:  George Koutsoudakis; Alexia Paris de León; Carolina Herrera; Marcus Dorner; Gemma Pérez-Vilaró; Sébastien Lyonnais; Santiago Grijalvo; Ramon Eritja; Andreas Meyerhans; Gilles Mirambeau; Juana Díez
Journal:  Antimicrob Agents Chemother       Date:  2017-04-24       Impact factor: 5.191

2.  Association of hepatitis C viral infection with incidence and progression of chronic kidney disease in a large cohort of US veterans.

Authors:  Miklos Z Molnar; Hazem M Alhourani; Barry M Wall; Jun L Lu; Elani Streja; Kamyar Kalantar-Zadeh; Csaba P Kovesdy
Journal:  Hepatology       Date:  2015-03-20       Impact factor: 17.425

3.  Mutations in hepatitis C virus E2 located outside the CD81 binding sites lead to escape from broadly neutralizing antibodies but compromise virus infectivity.

Authors:  Zhen-yong Keck; Sophia H Li; Jinming Xia; Thomas von Hahn; Peter Balfe; Jane A McKeating; Jeroen Witteveldt; Arvind H Patel; Harvey Alter; Charles M Rice; Steven K H Foung
Journal:  J Virol       Date:  2009-03-25       Impact factor: 5.103

4.  Macrophages transmit human immunodeficiency virus type 1 products to CD4-negative cells: involvement of matrix metalloproteinase 9.

Authors:  Claudia Muratori; Antonella Sistigu; Eliana Ruggiero; Mario Falchi; Ilaria Bacigalupo; Clelia Palladino; Elena Toschi; Maurizio Federico
Journal:  J Virol       Date:  2007-06-20       Impact factor: 5.103

Review 5.  Human cell types important for hepatitis C virus replication in vivo and in vitro: old assertions and current evidence.

Authors:  Dennis Revie; Syed Zaki Salahuddin
Journal:  Virol J       Date:  2011-07-11       Impact factor: 4.099

Review 6.  Neutralizing antibody response to hepatitis C virus.

Authors:  Yong Wang; Zhen-Yong Keck; Steven K H Foung
Journal:  Viruses       Date:  2011-11-02       Impact factor: 5.048

Review 7.  Hepatitis C virus evasion mechanisms from neutralizing antibodies.

Authors:  Caterina Di Lorenzo; Allan G N Angus; Arvind H Patel
Journal:  Viruses       Date:  2011-11-15       Impact factor: 5.818

8.  Autophagy-associated dengue vesicles promote viral transmission avoiding antibody neutralization.

Authors:  Yan-Wei Wu; Clément Mettling; Shang-Rung Wu; Chia-Yi Yu; Guey-Chuen Perng; Yee-Shin Lin; Yea-Lih Lin
Journal:  Sci Rep       Date:  2016-08-25       Impact factor: 4.379

9.  CD81 is dispensable for hepatitis C virus cell-to-cell transmission in hepatoma cells.

Authors:  Jeroen Witteveldt; Matthew J Evans; Julia Bitzegeio; George Koutsoudakis; Ania M Owsianka; Allan G N Angus; Zhen-Yong Keck; Steven K H Foung; Thomas Pietschmann; Charles M Rice; Arvind H Patel
Journal:  J Gen Virol       Date:  2009-01       Impact factor: 3.891

10.  Hepatitis C virus association with peripheral blood B lymphocytes potentiates viral infection of liver-derived hepatoma cells.

Authors:  Zania Stamataki; Claire Shannon-Lowe; Jean Shaw; David Mutimer; Alan B Rickinson; John Gordon; David H Adams; Peter Balfe; Jane A McKeating
Journal:  Blood       Date:  2008-10-06       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.